Quick Answer
Sarepta Therapeutics, Inc. reported Shares Outstanding of 104.96 million shares for fiscal year 2025.
Sarepta Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 104.96M | +8.3% |
| 2024 | 96.90M | +3.4% |
| 2023 | 93.73M | +6.6% |
| 2022 | 87.95M | +0.9% |
| 2021 | 87.13M | +9.8% |
| 2020 | 79.37M | +5.6% |
| 2019 | 75.18M | +5.8% |
| 2018 | 71.07M | +9.7% |
| 2017 | 64.79M | +18.3% |
| 2016 | 54.76M | +20.0% |
| 2015 | 45.63M | +10.5% |
| 2014 | 41.31M | +9.4% |
| 2013 | 37.75M | +19.1% |
| 2012 | 31.70M | +40.1% |
| 2011 | 22.62M | -79.9% |
| 2010 | 112.35M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 104.77M | +9.7% | +7.2% |
| June 30, 2025 | 97.71M | +2.5% | -0.6% |
| March 31, 2025 | 98.25M | +4.0% | +1.4% |
| December 31, 2024 | 96.90M | +3.4% | +1.5% |
| September 30, 2024 | 95.49M | +2.1% | +0.2% |
| June 30, 2024 | 95.28M | +2.2% | +0.8% |
| March 31, 2024 | 94.49M | +1.4% | +0.8% |
| December 31, 2023 | 93.73M | +6.6% | +0.2% |
- Sarepta Therapeutics, Inc. showed an increase of +8.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Sarepta Therapeutics, Inc.’s shares outstanding has declined by 6.6% (from 112.35 million shares to 104.96 million shares).
- The most recent figure is from Sarepta Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: